Leadership Overview
Eurofins has 10 executives leading key functions including regional operations, financial oversight, technology development, and specialized laboratory management.
Committed to advancing global health through rigorous analytical testing, Eurofins delivers essential scientific support services across pharmaceutical, food, and environmental sectors to ensure safety and quality standards worldwide.
Committed to advancing global health through rigorous analytical testing, Eurofins delivers essential scientific support services across pharmaceutical, food, and environmental sectors to ensure safety and quality standards worldwide.
Leadership Roles at Eurofins
Alexandra Kim - Chief Financial Officer, Business Line
Alexandra Kim, the Chief Financial Officer, Business Line at Eurofins, manages the financial health and fiscal strategy for specific operational segments. Overseeing budget planning and capital allocation, the Chief Financial Officer, Business Line ensures that resources support the growth of analytical testing and laboratory services. This role involves analyzing market trends to identify investment opportunities that align with the long-term objectives of the company. Alexandra Kim works closely with operational leaders to monitor profitability and optimize cost structures across various business lines. By implementing rigorous financial controls, the Chief Financial Officer, Business Line maintains transparency and accountability in all fiscal reporting. This leadership position supports the overall financial stability of the organization, enabling sustained investment in scientific research and infrastructure. Through strategic financial planning, the Chief Financial Officer, Business Line facilitates the expansion of service capabilities, ensuring that the company remains a dominant force in the global life sciences testing market.
Jatin Vij - Chief Financial Officer, Business Lines (Multiple, Asia)
Jatin Vij, the Chief Financial Officer, Business Lines (Multiple, Asia) at Eurofins, directs the financial operations across diverse business units within the Asian market. Overseeing regional fiscal performance, the Chief Financial Officer, Business Lines (Multiple, Asia) ensures that local laboratory operations adhere to corporate financial standards while meeting regional growth targets. This role involves managing complex financial reporting and tax compliance across multiple jurisdictions. Jatin Vij analyzes regional market dynamics to provide actionable insights that guide strategic decision-making for the company. By optimizing working capital and managing investment portfolios, the Chief Financial Officer, Business Lines (Multiple, Asia) supports the expansion of testing services in the region. This leadership position requires close coordination with global finance teams to ensure alignment with the overarching corporate strategy. Through disciplined financial management, the Chief Financial Officer, Business Lines (Multiple, Asia) drives profitability and operational efficiency, strengthening the presence of the company in the competitive Asian life sciences sector.
Takahiko Hagiwara - Group President (Japan)
Takahiko Hagiwara, the Group President (Japan) at Eurofins, leads the strategic direction and operational execution for all business activities within the Japanese market. Overseeing the integration of laboratory services, the Group President (Japan) ensures that the company meets the specific regulatory and quality demands of the local pharmaceutical and food sectors. This role involves cultivating relationships with key industry stakeholders and government bodies to facilitate market growth. Takahiko Hagiwara manages the performance of regional teams, ensuring that service delivery remains consistent with global standards. By identifying local market opportunities, the Group President (Japan) drives the expansion of specialized testing capabilities. This leadership position requires a deep understanding of the unique business environment in Japan to effectively navigate competitive challenges. Through the implementation of localized strategies, the Group President (Japan) enhances the market share of the company, ensuring that the organization remains a trusted partner for scientific support services in the region.
Marisa Feller - President
Marisa Feller, the President at Eurofins, directs the strategic operations of specific business divisions focused on clinical diagnostics and laboratory support. Overseeing the development of new testing protocols, the President ensures that the company provides high-quality, reliable results for healthcare providers and patients. This role involves managing the operational lifecycle of diagnostic services, from initial research to final reporting. Marisa Feller collaborates with other executive leaders to align division goals with the broader mission of the company. By fostering a culture of scientific excellence, the President drives innovation in diagnostic methodologies. This leadership position requires constant monitoring of industry standards to ensure compliance and service quality. Through the effective management of specialized teams, the President supports the growth of the clinical diagnostics portfolio. Marisa Feller maintains a focus on operational efficiency and service expansion, ensuring that the company continues to deliver critical health insights to the global market.
James Jung - President
James Jung, the President at Eurofins, manages the operational strategy for business units dedicated to environmental and consumer product testing. Overseeing the performance of testing facilities, the President ensures that all services meet rigorous safety and quality standards. This role involves directing the implementation of new testing technologies that address evolving environmental regulations. James Jung works with technical teams to optimize laboratory workflows, increasing the capacity to handle complex sample analysis. By focusing on client satisfaction and service reliability, the President strengthens the market position of the company in the environmental sector. This leadership position requires strategic oversight of resource allocation to support business growth. Through the effective management of operational teams, the President drives the delivery of essential scientific data that helps clients maintain compliance and product safety. James Jung ensures that the organization remains a leader in providing accurate, timely testing services for diverse industrial applications.
Andrew Buschow - President of Eurofins Rapid Microbiology Laboratories
Andrew Buschow, the President of Eurofins Rapid Microbiology Laboratories at Eurofins, leads the specialized division focused on accelerated microbial testing solutions. Overseeing the deployment of rapid testing technologies, the President of Eurofins Rapid Microbiology Laboratories ensures that pharmaceutical and food clients receive critical safety data with minimal turnaround time. This role involves managing the technical development of innovative microbiology assays that improve laboratory throughput. Andrew Buschow collaborates with research teams to validate new testing methods that meet stringent regulatory requirements. By focusing on the unique needs of the microbiology sector, the President of Eurofins Rapid Microbiology Laboratories drives the growth of this specialized business line. This leadership position requires a deep commitment to scientific precision and operational speed. Through the effective management of laboratory operations, the President of Eurofins Rapid Microbiology Laboratories enhances the ability of the company to provide essential safety testing, ensuring that clients can make rapid, informed decisions regarding product quality.

Elizabeth Winger - President
Elizabeth Winger, the President at Eurofins, oversees the strategic management of business lines focused on pharmaceutical product testing and development support. Directing the operations of specialized laboratories, the President ensures that all testing services adhere to global quality standards and regulatory guidelines. This role involves coordinating with pharmaceutical clients to provide comprehensive analytical support throughout the product lifecycle. Elizabeth Winger manages the performance of technical teams to ensure the delivery of accurate, high-quality data for drug development and quality control. By fostering innovation in testing methodologies, the President drives the expansion of service capabilities in the pharmaceutical sector. This leadership position requires close collaboration with other C-suite executives to align division strategies with the overall corporate mission. Through the effective management of operational resources, the President supports the growth of the company, ensuring that the organization remains a critical partner for pharmaceutical companies worldwide in their pursuit of safe and effective medical products.
Scott Fyfe - Chief Technology Officer
Scott Fyfe, the Chief Technology Officer at Eurofins, architects the digital infrastructure supporting the global network of laboratories. Overseeing the implementation of advanced data management systems, the Chief Technology Officer ensures that analytical testing processes remain at the forefront of scientific innovation. This role involves integrating automated diagnostic tools to increase laboratory efficiency and data accuracy. Scott Fyfe collaborates with cross-functional teams to deploy secure, scalable platforms that handle complex testing requirements for pharmaceutical and environmental clients. By prioritizing cybersecurity and data integrity, the Chief Technology Officer protects the intellectual property and sensitive information managed by the company. This leadership position drives the digital transformation strategy, enabling faster turnaround times for critical testing services. Through the continuous evaluation of emerging technologies, the Chief Technology Officer maintains the competitive edge of the organization in the rapidly evolving life sciences market, ensuring robust technological support for all business lines.
Karthik Nd - Regional Managing Director
Karthik Nd, the Regional Managing Director at Eurofins, directs all operational activities across the assigned territory. Overseeing the integration of laboratory networks, the Regional Managing Director ensures that analytical testing services meet stringent international quality benchmarks. This leadership role involves scaling infrastructure to support clinical diagnostics and environmental testing demands. By optimizing resource allocation, Karthik Nd directly impacts the efficiency of regional testing facilities. The Regional Managing Director coordinates with global leadership to align local output with the broader corporate mission of providing high-quality scientific support. Through the implementation of standardized protocols, the Regional Managing Director maintains operational excellence across diverse market segments. This focus on regional growth and technical precision strengthens the overall market position of the company while ensuring that clients receive accurate, timely data for critical decision-making processes in the life sciences industry.
Abedulfattah Al Rawwas - Regional Managing Director
Abedulfattah Al Rawwas, the Regional Managing Director at Eurofins, manages the strategic expansion of laboratory services within the designated operational zone. Focusing on the food and consumer product testing sectors, the Regional Managing Director drives initiatives that enhance laboratory throughput and service reliability. This position requires constant collaboration with technical teams to implement advanced testing methodologies that address emerging regulatory requirements. Abedulfattah Al Rawwas monitors performance metrics to ensure that regional facilities maintain high standards of accuracy and compliance. By streamlining supply chain logistics for testing materials, the Regional Managing Director improves operational agility. This leadership role supports the broader corporate objective of delivering comprehensive scientific solutions to a global client base. Through the effective management of regional assets, the Regional Managing Director fosters sustainable growth and reinforces the reputation of the company as a leader in analytical testing and diagnostic support services.
Explore Leadership Teams in Business Services
Rho, founded in 1984, is a privately-held, contract research organization (CRO) located near Chapel Hill, NC. The company provides a full range of clinical research services across the entire drug development process.
Company Leadership LM
BD
AH
AF
Central Metallurgical Research and Development Institute (CMRDI) is a research institute affiliated to the Ministery of Scientific Research. The mission of the institute is to enhance the competitiveness of the Egyptian industry and the welfare of the society through technological development and technology transfer. CMRDI offers services to industry covering research projects, consultancy, technical services, training, testing and certification. Over almost three decades of collaboration with Egyptian industry, these services have been focused on the actual demands of the client and application in the company, giving the institute a profile of needs pull rather than technology push. CMRDI has a longstanding and successful collaboration with many national and overseas R&D institutions, which guarantees a sound scientific basis. CMRDI has also largely benefited from cooperation with international agencies such as JICA (Japan), TNO (Netherlands) and SIDA (Sweden). Thanks to this support, CMRDI was able to play an effective role in transferring many technologies to the Egyptian industries as well as other African and Middle-East countries.
Company Leadership MN
IA
AY
AN
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. they are here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. they partner with healthcare practitioners to ensure they're solving real problems for them. And they build value in the company for investors by filling real market needs. The company's in-house R&D team of experienced drug discovery scientists develops transformative novel molecules with a focus on the endocrine system and G protein-coupled receptors (GPCRs). Its pipeline is strategically designed to deliver innovative therapies.
Company Leadership

NL
Seegene was founded in 2000. This company provides the developing of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Their headquarters are located in Seoul, South Korea.
Company Leadership DL
JC
JY
ML